Coala Life strengthens team as part of global expansion

2019-06-20

STOCKHOLM 2019-06-20. The Board of Directors at Coala Life has appointed Dan Pitulia as the new CEO of Coala Life AB effective July 1st, 2019. Philip Siberg, the current CEO and co-founder, will lead Coalas entry on the US market as the new head of Coala Life Inc. Additional key individuals have been recruited as part of the global expansion strategy.

The Swedish medtech Company Coala Life AB received during the spring of 2019 a 510(k) market clearance from the US Food and Drug Administration, FDA, and shortly thereafter raised 92 million SEK to enable the international expansion and to establish a presence on the important US market. The Board has today appointed Dan Pitulia as CEO to lead the company from July 1, 2019 and Philip Siberg will take on the role as President of Coala Life Inc from the same date.

-We are creating a strong team with Dan Pitulia and Philip Siberg to take the company to the next level. Dan has an impressive track record to lead, build and create shareholder value in medical device companies. Philip is one of the founders and the right person to build our business on the very important US market together with Dan, says Liselott Kilaas, Chairman of the Board of Coala Life

Dan Pitulia is a serial entrepreneur in the life science field and also one of Coala’s founding shareholders. He has advised the Board and the management team since the start of the Company alongside being CEO at QleanAir Scandinavia and previously Carmel Pharma and Entific Medical Systems as well as leading positions at Swedish Match and Mölnlycke. Dan Pitulia is currently the Chairman of Memira – the largest refractive surgery chain in Scandinavia.

-I look forward to help drive the international expansion of the very innovative Coala Heart Monitor where my previous experience will be of value. The Coala concept of engaging also the patient in an automated ECG interpretation will help address one of the largest medical issues facing us, comments Dan Pitulia.

-I am so excited to lead Coala in to the US market and fulfill the goals and visions that we founded the compmay upon. We’re charging into the world’s largest medical device market with solutios that not just are of benefit to the patients, but also for healthcare providers and the payors, comments Philip Siberg.

The Company is simultaneously strengthening the organization with a new CFO, a VP Operations US market and several other critical positioners within Sales, Marketing, R&D and Quality.

Coala Life is a Swedish digital health venture focused on cardiac diagnostics and digital health. The company has developed a portfolio of patented medical products and services for user-centered digital remote monitoring and screening of the heart based on advanced and smart algorithms. Coala’s solutions enable analysis, remote monitoring, more effective cardiac assessments and integrated care services, all in real time. Coala was named one of five global Cool Vendors within the Health and Wellness market by Gartner Group in 2018 and recognized as of the 100 Global Leaders in Digital Health by the Journal of mHealth. For more information see www.coalalife.com Follow your Heart®

STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets. The Swedish medtech company Coala Life, …

With alumni such as Minecraft, Skype, Spotify, King and iZettle, Stockholm is often called Europe’s unicorn factory. And its got plenty of new, young startups to showcase, too. Over the past decade, Stockholm has experienced a spike in venture capital and government funding, with more and more co-working spaces popping up around the city. But …

Meet the Coala team at the European Society of Cardiology 2019, the world’s largest cardiovascular congress, this year in Paris. August 31- September 04, 2019 Paris Expo Porte de Versailles, Paris, France Visit our stand #F910 to talk more about how our healthcare solutions can facilitate your work, increase patient engagement and lower your …

STOCKHOLM, JUNE 27th, 2019. Coala Life today announced the expanded closing of previously announced A-series round of approximately SEK 11 million. The proceeds are intended to accelerate the commercialization process and establish the company on the US market. Investors includes the investment company Blue and members of the management team. Swedish medical technology company Coala …